Clinical Research
Total Trials
27
As Lead Sponsor
17
As Collaborator
10
Total Enrollment
17,389
NCT00578240
Molecular Studies and Clinical Correlations in Human Prostatic Disease
Phase: N/A
Role: Collaborator
Start: Apr 30, 1990
Completion: Dec 31, 2026
NCT00002576
Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma
Phase: Phase 3
Role: Lead Sponsor
Start: Nov 30, 1992
Completion: Jan 31, 2001
NCT00002582
Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
Start: Jun 30, 1993
Completion: Apr 30, 2007
NCT00005590
Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma
Start: Aug 31, 1999
Completion: Sep 30, 2005
NCT00024297
Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters
Start: Oct 31, 1999
Completion: Feb 28, 2009
NCT00031863
Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer
Start: Feb 28, 2001
Completion: Sep 30, 2007
NCT00039546
Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery
Start: Aug 31, 2001
Completion: Not specified
NCT00032136
Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer
Start: Dec 31, 2001
Completion: Apr 30, 2009
NCT00242359
A Pilot Study Investigating the Effect of Omalizumab (Xolair) in Work-Related Animal Induced Asthma
Phase: Phase 4
Start: Nov 30, 2005
Completion: Jan 31, 2009
NCT00522782
Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children
Start: Aug 31, 2007
NCT00557284
Efficacy Study of Montelukast in Atopic Dermatitis Induced by Food Allergens
Start: Mar 31, 2008
Completion: May 31, 2009
NCT01048918
Characterization of Circulating Tumor Cells (CTC-s) in Patients With Locally Advanced or Metastatic Stage IV Breast Cancer
Start: Sep 4, 2008
Completion: Apr 8, 2022
NCT00894231
Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis
Start: Jan 31, 2009
Completion: Aug 31, 2009
NCT00908557
Impact of Readability Improvements on the Comprehension of Written Information Given to Clinical Trial Patients: a RCT
Start: Apr 30, 2009
Completion: Mar 31, 2014
NCT01094964
Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer
Start: Oct 31, 2009
NCT01391260
Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)
Phase: Phase 2
Start: Jul 31, 2011
Completion: Jul 31, 2017
NCT02715375
Investigate the Effect of the CREON2000A on Asthma Control in Children With Mild to Moderate Persistent Asthma
Start: Mar 10, 2016
Completion: Oct 15, 2020
NCT02814630
Three-month, Single-center Study to Identify Biomarkers/Response to Xolair Therapy in Chronic Idiopathic Urticaria
Start: Sep 30, 2016
Completion: Nov 2, 2018
NCT03131102
Perioperative Early Tiredness (Acute Fatigue) in Patients With Epithelial Ovarian Cancer
Start: Aug 29, 2017
Completion: Oct 9, 2018
NCT03418610
Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea
Start: Dec 6, 2017
Completion: Jan 9, 2019
NCT06690047
Treatment of Hereditary Angioedema Prodrome with Recombinant C1-esterase Inhibitor (Ruconest)
Start: Aug 14, 2018
Completion: Apr 28, 2022
NCT04008784
Improvement of Short Term Outcome of Mild to Moderate Atopic Dermatitis Using a Combination of Crisaborole and a Concomitant Topical Corticosteroid Over a 8 Week Period
Start: Sep 16, 2019
Completion: Sep 8, 2020
NCT04465890
A Phase II Study of Subcutaneously Injected PD-L1 Antibody ASC22 in Chronic Hepatitis B Patients
Start: Jul 17, 2020
Completion: Aug 9, 2024
NCT04891666
A Trial to Evaluate the Efficacy and Safety of Lactobacillus Plantarum DSM 33464 on Blood Lead Levels in Children
Start: Jul 6, 2021
Completion: Mar 17, 2023
NCT06818474
Lanadelumab in Long-term Prophylaxis of Acquired Angioedema
Start: Jun 1, 2024
Completion: Dec 1, 2027
NCT06437171
FeNO as a Marker of Allergic Reactions to OFC and Response of OMA Treatment in Multiple FA
Start: Jun 3, 2024
NCT07000708
VITAL: Vaccination, Immunity, Time-restricted Eating, Aging and Lifestyle
Start: Sep 10, 2025
Completion: Jan 31, 2027
Loading map...